Pluri (PLUR) EBT Growth (1y) (2011 - 2025)

Pluri (PLUR) EBT Growth (1y) (2011 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -88.68%
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 13.34%
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -51.60%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -313.33%
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -79.57%
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -230.18%
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 71.54%
9 Abivax 94.37 Bn 94.37 Bn - -
10 Pluri 21.39 Mn 21.87 Mn 86,000.00 -121.22%

Historic Data

Download Data
DateValue
Dec 31, 2025 -121.22%
Sep 30, 2025 -1.72%
Jun 30, 2025 -9.63%
Mar 31, 2025 2.43%
Dec 31, 2024 42.72%
Sep 30, 2024 -7.96%
Jun 30, 2024 7.57%
Mar 31, 2024 21.39%
Dec 31, 2023 21.22%
Sep 30, 2023 21.44%
Jun 30, 2023 23.85%
Mar 31, 2023 30.15%
Dec 31, 2022 36.16%
Sep 30, 2022 37.79%
Jun 30, 2022 39.11%
Mar 31, 2022 26.36%
Dec 31, 2021 17.43%
Sep 30, 2021 -30.95%
Jun 30, 2021 -71.33%
Mar 31, 2021 -92.26%